Insiders · Profile

Cohen Yuval

Chief Executive Officer at Corbus Pharmaceuticals. Filing since 3 Dec 2014. CIK 0001626003

Company

Date

Role

Action

Shares

Amount

Of holding

CRBP Corbus Pharmaceuticals Holdings, Inc.

7 Aug 2026

Chief Executive Officer

Sold on a plan

17,000

$171.40K

9.8%

CRBP Corbus Pharmaceuticals Holdings, Inc.

13 Feb 2026

Chief Executive Officer

Sold on a plan

13,871

$107.95K

7.4%

CRBP Corbus Pharmaceuticals Holdings, Inc.

27 Oct 2025

Chief Executive Officer

Sold on a plan

8,973

$153.80K

6.1%

CRBP Corbus Pharmaceuticals Holdings, Inc.

24 Oct 2025

Chief Executive Officer

Sold on a plan

18,660

$317.41K

11.9%

CRBP Corbus Pharmaceuticals Holdings, Inc.

14 Feb 2025

Chief Executive Officer

Sold on a plan

7,134

$62.46K

4.9%

CRBP Corbus Pharmaceuticals Holdings, Inc.

18 Jun 2024

Chief Executive Officer

Sold on a plan

22,938

$968.83K

22.9%

CRBP Corbus Pharmaceuticals Holdings, Inc.

17 Jun 2024

Chief Executive Officer

Sold on a plan

11,103

$510.96K

11.6%

CRBP Corbus Pharmaceuticals Holdings, Inc.

14 Jun 2024

Chief Executive Officer

Sold on a plan

29,317

$1.47M

25.8%

CRBP Corbus Pharmaceuticals Holdings, Inc.

10 Aug 2022

Chief Executive Officer

Bought

3,800

$1.00K

4.0%

CRBP Corbus Pharmaceuticals Holdings, Inc.

16 May 2022

Chief Executive Officer

Bought

10,500

$2.63K

12.5%

CRBP Corbus Pharmaceuticals Holdings, Inc.

9 Mar 2022

Chief Executive Officer

Bought

8,600

$3.18K

11.4%

CRBP Corbus Pharmaceuticals Holdings, Inc.

11 Nov 2020

Chief Executive Officer

Bought

4,240

$5.13K

6.0%

CRBP Corbus Pharmaceuticals Holdings, Inc.

17 Mar 2020

Chief Executive Officer

Bought

4,300

$15.01K

6.4%

CRBP Corbus Pharmaceuticals Holdings, Inc.

12 Nov 2019

Chief Executive Officer

Bought

1,430

$6.09K

2.2%

CRBP Corbus Pharmaceuticals Holdings, Inc.

12 Aug 2019

Chief Executive Officer

Bought

1,175

$7.12K

1.8%

CRBP Corbus Pharmaceuticals Holdings, Inc.

13 May 2019

Chief Executive Officer

Bought

995

$6.95K

1.6%

CRBP Corbus Pharmaceuticals Holdings, Inc.

14 Mar 2019

Chief Executive Officer

Bought

1,530

$9.93K

2.5%

CRBP Corbus Pharmaceuticals Holdings, Inc.

15 May 2018

Chief Executive Officer

Bought

1,725

$10.09K

2.9%

CRBP Corbus Pharmaceuticals Holdings, Inc.

14 Mar 2018

Chief Executive Officer

Bought

1,160

$7.99K

2.0%

CRBP Corbus Pharmaceuticals Holdings, Inc.

10 Nov 2017

Chief Executive Officer

Bought

1,000

$7.17K

1.7%

CRBP Corbus Pharmaceuticals Holdings, Inc.

11 Aug 2017

Chief Executive Officer

Bought

1,695

$10.17K

3.0%

CRBP Corbus Pharmaceuticals Holdings, Inc.

11 May 2017

Chief Executive Officer

Bought

3,250

$19.54K

6.2%

CRBP Corbus Pharmaceuticals Holdings, Inc.

22 Nov 2016

Chief Executive Officer

Bought

1,340

$10.24K

11.7%

CRBP Corbus Pharmaceuticals Holdings, Inc.

6 Jun 2016

Chief Executive Officer

Bought

1,500

$5.01K

15.0%

CRBP Corbus Pharmaceuticals Holdings, Inc.

18 May 2016

Chief Executive Officer

Bought

2,125

$5.10K

27.0%

CRBP Corbus Pharmaceuticals Holdings, Inc.

23 Nov 2015

Chief Executive Officer

Bought

535

$941.23

8.5%

CRBP Corbus Pharmaceuticals Holdings, Inc.

13 Nov 2015

Chief Executive Officer

Bought

850

$1.47K

15.6%

CRBP Corbus Pharmaceuticals Holdings, Inc.

24 Aug 2015

Chief Executive Officer

Bought

550

$1.07K

11.2%

CRBP Corbus Pharmaceuticals Holdings, Inc.

17 Aug 2015

Chief Executive Officer

Bought

2,100

$4.03K

75.0%

CRBP Corbus Pharmaceuticals Holdings, Inc.

15 Jun 2015

Chief Executive Officer

Bought

900

$2.95K

47.4%

CRBP Corbus Pharmaceuticals Holdings, Inc.

17 Dec 2014

Chief Executive Officer

Bought

400

$1.46K

26.7%

CRBP Corbus Pharmaceuticals Holdings, Inc.

4 Dec 2014

Chief Executive Officer

Bought

500

$1.65K

50.0%

CRBP Corbus Pharmaceuticals Holdings, Inc.

3 Dec 2014

Chief Executive Officer

Bought

1,000

$3.20K

opened

33 decisions on file.